{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:43:09Z","timestamp":1724978589952},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,29]]},"DOI":"10.7759\/cureus.68084","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T09:25:44Z","timestamp":1724923544000},"source":"Crossref","is-referenced-by-count":0,"title":["Emergence of Achromobacter xylosoxidans Bacteremia in a Tertiary Care Center: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Karthiga","family":"Dhakshna Murthi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swetha","family":"Naik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanmuga Leela","family":"Arumugam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manonmoney","family":"J","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leela","family":"KV","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01643962","article-title":"Infections due to Achromobacter xylosoxidans. Case report and review of the literature","volume":"14","author":"Chandrasekar PH","year":"1986","unstructured":"Chandrasekar PH, Arathoon E, Levine DP. Infections due to Achromobacter xylosoxidans. Case report and review of the literature. Infection. 1986, 14:279-82. 10.1007\/BF01643962","journal-title":"Infection"},{"key":"ref2","article-title":"Achromobacter xylosoxidans bacteremia: clinical and microbiological features in a 10-year case series","volume":"31","author":"Barrag\u00e1n EP","year":"2018","unstructured":"Barrag\u00e1n EP, P\u00e9rez JS, Corbella L, Orellana M\u00c1, Fern\u00e1ndez-Ruiz M. Achromobacter xylosoxidans bacteremia: clinical and microbiological features in a 10-year case series. Rev Esp Quimioter. 2018, 31:268-73.","journal-title":"Rev Esp Quimioter"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01025-20","article-title":"Achromobacter infections and treatment options","volume":"64","author":"Isler B","year":"2020","unstructured":"Isler B, Kidd TJ, Stewart AG, Harris P, Paterson DL. Achromobacter infections and treatment options. Antimicrob Agents Chemother. 2020, 64:01025-20. 10.1128\/AAC.01025-20","journal-title":"Antimicrob Agents Chemother"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.39.11.3942-3945.2001","article-title":"Identification and antimicrobial susceptibility of Alcaligenes xylosoxidans isolated from patients with cystic fibrosis","volume":"39","author":"Saiman L","year":"2001","unstructured":"Saiman L, Chen Y, Tabibi S, et al.. Identification and antimicrobial susceptibility of Alcaligenes xylosoxidans isolated from patients with cystic fibrosis. J Clin Microbiol. 2001, 39:3942-5. 10.1128\/JCM.39.11.3942-3945.2001","journal-title":"J Clin Microbiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2011.09.001","article-title":"MALDI-TOF MS improves routine identification of non-fermenting Gram negative isolates from cystic fibrosis patients","volume":"11","author":"Fern\u00e1ndez-Olmos A","year":"2012","unstructured":"Fern\u00e1ndez-Olmos A, Garc\u00eda-Castillo M, Morosini MI, Lamas A, M\u00e1iz L, Cant\u00f3n R. MALDI-TOF MS improves routine identification of non-fermenting Gram negative isolates from cystic fibrosis patients. J Cyst Fibros. 2012, 11:59-62. 10.1016\/j.jcf.2011.09.001","journal-title":"J Cyst Fibros"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11121686","article-title":"Successful treatment of aortic endocarditis by Achromobacter xylosoxidans with cefiderocol combination therapy in a non-Hodgkin lymphoma patient: case report and literature review","volume":"11","author":"La Bella G","year":"2022","unstructured":"La Bella G, Salvato F, Minafra GA, et al.. Successful treatment of aortic endocarditis by Achromobacter xylosoxidans with cefiderocol combination therapy in a non-Hodgkin lymphoma patient: case report and literature review. Antibiotics (Basel). 2022, 11:1686-2022. 10.3390\/antibiotics11121686","journal-title":"Antibiotics (Basel)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.idcr.2022.e01421","article-title":"Mitral endocarditis caused by Achromobacter xylosoxidans in an older patient: case report and literature review","volume":"27","author":"Kengni Tameze J","year":"2022","unstructured":"Kengni Tameze J, Korpak K, Compagnie M, Levie H, Cherifi S, Lali SE. Mitral endocarditis caused by Achromobacter xylosoxidans in an older patient: case report and literature review. IDCases. 2022, 27:01421. 10.1016\/j.idcr.2022.e01421","journal-title":"IDCases"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2014.00138","article-title":"Outbreak of Achromobacter xylosoxidans in an Italian Cystic fibrosis center: genome variability, biofilm production, antibiotic resistance, and motility in isolated strains","volume":"5","author":"Trancassini M","year":"2014","unstructured":"Trancassini M, Iebba V, Citer\u00e0 N, et al.. Outbreak of Achromobacter xylosoxidans in an Italian Cystic fibrosis center: genome variability, biofilm production, antibiotic resistance, and motility in isolated strains. Front Microbiol. 2014, 5:138. 10.3389\/fmicb.2014.00138","journal-title":"Front Microbiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1396929","article-title":"Stenotrophomonas, Achromobacter, and nonmelioid Burkholderia species: antimicrobial resistance and therapeutic strategies","volume":"36","author":"Abbott IJ","year":"2015","unstructured":"Abbott IJ, Peleg AY. Stenotrophomonas, Achromobacter, and nonmelioid Burkholderia species: antimicrobial resistance and therapeutic strategies. Semin Respir Crit Care Med. 2015, 36:99-110. 10.1055\/s-0034-1396929","journal-title":"Semin Respir Crit Care Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.42052","article-title":"Sepsis due to Achromobacter xylosoxidans in a tertiary care centre: case series","volume":"15","author":"Mudey G","year":"2023","unstructured":"Mudey G, Kunjalwar R, Sahu G, Mahajan SM, Meshram S. Sepsis due to Achromobacter xylosoxidans in a tertiary care centre: case series. Cureus. 2023, 15:42052. 10.7759\/cureus.42052","journal-title":"Cureus"},{"key":"ref11","article-title":"Achromobacter xylosoxidans an emerging opportunistic nosocomial pathogen: a retrospective study in a tertiary care hospital","volume":"26","author":"Bhatawadekar SM","year":"2024","unstructured":"Bhatawadekar SM, Babu A, Kumar M, Modak MS. Achromobacter xylosoxidans an emerging opportunistic nosocomial pathogen: a retrospective study in a tertiary care hospital. JK Science. 2024, 26:235.","journal-title":"JK Science"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.18203\/2320-6012.ijrms20193400","article-title":"Achromobacter: an emerging nosocomial pathogen","volume":"7","author":"Pandey K","year":"2019","unstructured":"Pandey K, Nautiyal S. Achromobacter: an emerging nosocomial pathogen. Int J Res Med Sci. 2019, 7:3090-44. 10.18203\/2320-6012.ijrms20193400","journal-title":"Int J Res Med Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.26048","article-title":"Achromobacter xylosoxidans bacteremia in a liver transplant patient: a case report and literature review","volume":"14","author":"Barakat M","year":"2022","unstructured":"Barakat M, Sajid J. Achromobacter xylosoxidans bacteremia in a liver transplant patient: a case report and literature review. Cureus. 2022, 14:26048. 10.7759\/cureus.26048","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/23.3.569","article-title":"Achromobacter xylosoxidans bacteremia: report of four cases and review of the literature","volume":"23","author":"Duggan JM","year":"1996","unstructured":"Duggan JM, Goldstein SJ, Chenoweth CE, Kauffman CA, Bradley SF. Achromobacter xylosoxidans bacteremia: report of four cases and review of the literature. Clin Infect Dis. 1996, 23:569-76. 10.1093\/clinids\/23.3.569","journal-title":"Clin Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjid.2013.01.008","article-title":"Bacteremia due to Achromobacter xylosoxidans in neonates: clinical features and outcome","volume":"17","author":"Turel O","year":"2013","unstructured":"Turel O, Kavuncuoglu S, Hosaf E, et al.. Bacteremia due to Achromobacter xylosoxidans in neonates: clinical features and outcome. Braz J Infect Dis. 2013, 17:450-4. 10.1016\/j.bjid.2013.01.008","journal-title":"Braz J Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1099\/jmmcr.0.T00022","article-title":"Achromobacter xylosoxidans: a rare pathogen for community\u2010acquired acute pancreatitis","volume":"1","author":"Otta S","year":"2014","unstructured":"Otta S, Swain B, Panigrahy R, Panda K, Debata N. Achromobacter xylosoxidans: a rare pathogen for community\u2010acquired acute pancreatitis. MicroSoc. 2014, 1:0. 10.1099\/jmmcr.0.T00022","journal-title":"MicroSoc"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.11.2.141-145.1980","article-title":"Clinical and laboratory characteristics of Achromobacter xylosoxidans infection","volume":"11","author":"Igra-Siegman Y","year":"1980","unstructured":"Igra-Siegman Y, Chmel H, Cobbs C. Clinical and laboratory characteristics of Achromobacter xylosoxidans infection. J Clin Microbiol. 1980, 11:141-5. 10.1128\/jcm.11.2.141-145.1980","journal-title":"J Clin Microbiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/276023-emergence-of-achromobacter-xylosoxidans-bacteremia-in-a-tertiary-care-center-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T09:25:47Z","timestamp":1724923547000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/276023-emergence-of-achromobacter-xylosoxidans-bacteremia-in-a-tertiary-care-center-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,29]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.68084","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,29]]}}}